Renal-Cell Carcinoma Pseudoprogression With Clinical Deterioration

To Hospice and Back

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
JournalClinical Genitourinary Cancer
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Hospices
Renal Cell Carcinoma
Immunotherapy
Infection

Keywords

  • Checkpoint inhibitors
  • Hyperprogression
  • Immune-related adverse events
  • Immunotherapy
  • Infection
  • SBRT

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

@article{c7f728df22884e6b8f2f2cb41a10a92e,
title = "Renal-Cell Carcinoma Pseudoprogression With Clinical Deterioration: To Hospice and Back",
keywords = "Checkpoint inhibitors, Hyperprogression, Immune-related adverse events, Immunotherapy, Infection, SBRT",
author = "Roy Elias and Payal Kapur and Ivan Pedrosa and James Brugarolas",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.clgc.2018.07.015",
language = "English (US)",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",

}

TY - JOUR

T1 - Renal-Cell Carcinoma Pseudoprogression With Clinical Deterioration

T2 - To Hospice and Back

AU - Elias, Roy

AU - Kapur, Payal

AU - Pedrosa, Ivan

AU - Brugarolas, James

PY - 2018/1/1

Y1 - 2018/1/1

KW - Checkpoint inhibitors

KW - Hyperprogression

KW - Immune-related adverse events

KW - Immunotherapy

KW - Infection

KW - SBRT

UR - http://www.scopus.com/inward/record.url?scp=85051140934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051140934&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2018.07.015

DO - 10.1016/j.clgc.2018.07.015

M3 - Article

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

ER -